Upregulation of inflammasome activity and increased gut permeability are associated with obesity in children and adolescents

V. Rainone, L. Schneider, I. Saulle, C. Ricci, M. Biasin, N. M. Al-Daghri, E. Giani, G. V. Zuccotti, M. Clerici, D. Trabattoni

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background:Immune activation contributes to the persistent state of inflammation associated with metabolic dysfunction in obesity. The specific immune receptors that sense metabolic stress signals and trigger inflammation are nevertheless largely unknown, and little is known on inflammatory and immune gene regulation in obesity.Methods:The study includes a cross-sectional and a longitudinal arm. Forty children and adolescents were enrolled: 22 obese subjects and 18 age-matched normal weight controls. Obese subjects participated in an 18-month therapeutic protocol, based on intensive lifestyle modification (dietary regimen, physical activity and behavioral interventions). Expression of genes involved in the inflammasome pathway, plasma concentration of the inflammasome-associated pro-inflammatory cytokines (interleukin (IL)-1β and IL-18) and indexes of microbial translocation (lipopolysaccharide (LPS), soluble CD14 (sCD14) and intestinal fatty acid-binding protein) were analyzed at baseline in obese subjects compared with controls, and after 18 months in obese subjects.Results:Cross-sectional analyses showed that the LPS-induced expression of genes involved in inflammasome (NLRP3, caspase 5 and NAIP), Nod-like receptors (NLRX1 and NOD1), downstream signaling (P2RX7, RAGE, RIPk2, TIRAP and BIRC2) and effector molecules (IFN-γ, IL-12β, IL-1β, CCL2, CCL5, IL-6 and TNFα) was significantly increased in obese subjects at baseline as compared with normal weight controls. The baseline plasma concentration of inflammasome-related cytokines (IL-1β and IL-18) and of microbial translocation markers (LPS and sCD14) was augmented in obese subjects as compared with controls as well. Longitudinal analyses indicated that intensive lifestyle modification resulted in a normalization of parameters in subjects with a significant reduction of BMI after 18 months.Conclusions:In children and adolescents, obesity is characterized by the activation of the inflammasome and by an alteration of gut permeability. Successful lifestyle modification is effective in reducing inflammation, suggesting that inhibition of the inflammasome may be a potential therapeutic strategy in obesity.

Original languageEnglish
Pages (from-to)1026-1033
Number of pages8
JournalInternational Journal of Obesity
Volume40
Issue number6
DOIs
Publication statusPublished - Jun 1 2016

Fingerprint

Inflammasomes
Pediatric Obesity
Permeability
Up-Regulation
Interleukin-1
Lipopolysaccharides
Life Style
Interleukin-18
Obesity
Inflammation
Cytokines
Diet Therapy
Gene Expression
Weights and Measures
Fatty Acid-Binding Proteins
Physiological Stress
Interleukin-12
Caspases
Interleukin-6
Cross-Sectional Studies

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Endocrinology, Diabetes and Metabolism

Cite this

Rainone, V., Schneider, L., Saulle, I., Ricci, C., Biasin, M., Al-Daghri, N. M., ... Trabattoni, D. (2016). Upregulation of inflammasome activity and increased gut permeability are associated with obesity in children and adolescents. International Journal of Obesity, 40(6), 1026-1033. https://doi.org/10.1038/ijo.2016.26

Upregulation of inflammasome activity and increased gut permeability are associated with obesity in children and adolescents. / Rainone, V.; Schneider, L.; Saulle, I.; Ricci, C.; Biasin, M.; Al-Daghri, N. M.; Giani, E.; Zuccotti, G. V.; Clerici, M.; Trabattoni, D.

In: International Journal of Obesity, Vol. 40, No. 6, 01.06.2016, p. 1026-1033.

Research output: Contribution to journalArticle

Rainone, V, Schneider, L, Saulle, I, Ricci, C, Biasin, M, Al-Daghri, NM, Giani, E, Zuccotti, GV, Clerici, M & Trabattoni, D 2016, 'Upregulation of inflammasome activity and increased gut permeability are associated with obesity in children and adolescents', International Journal of Obesity, vol. 40, no. 6, pp. 1026-1033. https://doi.org/10.1038/ijo.2016.26
Rainone, V. ; Schneider, L. ; Saulle, I. ; Ricci, C. ; Biasin, M. ; Al-Daghri, N. M. ; Giani, E. ; Zuccotti, G. V. ; Clerici, M. ; Trabattoni, D. / Upregulation of inflammasome activity and increased gut permeability are associated with obesity in children and adolescents. In: International Journal of Obesity. 2016 ; Vol. 40, No. 6. pp. 1026-1033.
@article{f80bc2d98163485bbb297a467a5be0dd,
title = "Upregulation of inflammasome activity and increased gut permeability are associated with obesity in children and adolescents",
abstract = "Background:Immune activation contributes to the persistent state of inflammation associated with metabolic dysfunction in obesity. The specific immune receptors that sense metabolic stress signals and trigger inflammation are nevertheless largely unknown, and little is known on inflammatory and immune gene regulation in obesity.Methods:The study includes a cross-sectional and a longitudinal arm. Forty children and adolescents were enrolled: 22 obese subjects and 18 age-matched normal weight controls. Obese subjects participated in an 18-month therapeutic protocol, based on intensive lifestyle modification (dietary regimen, physical activity and behavioral interventions). Expression of genes involved in the inflammasome pathway, plasma concentration of the inflammasome-associated pro-inflammatory cytokines (interleukin (IL)-1β and IL-18) and indexes of microbial translocation (lipopolysaccharide (LPS), soluble CD14 (sCD14) and intestinal fatty acid-binding protein) were analyzed at baseline in obese subjects compared with controls, and after 18 months in obese subjects.Results:Cross-sectional analyses showed that the LPS-induced expression of genes involved in inflammasome (NLRP3, caspase 5 and NAIP), Nod-like receptors (NLRX1 and NOD1), downstream signaling (P2RX7, RAGE, RIPk2, TIRAP and BIRC2) and effector molecules (IFN-γ, IL-12β, IL-1β, CCL2, CCL5, IL-6 and TNFα) was significantly increased in obese subjects at baseline as compared with normal weight controls. The baseline plasma concentration of inflammasome-related cytokines (IL-1β and IL-18) and of microbial translocation markers (LPS and sCD14) was augmented in obese subjects as compared with controls as well. Longitudinal analyses indicated that intensive lifestyle modification resulted in a normalization of parameters in subjects with a significant reduction of BMI after 18 months.Conclusions:In children and adolescents, obesity is characterized by the activation of the inflammasome and by an alteration of gut permeability. Successful lifestyle modification is effective in reducing inflammation, suggesting that inhibition of the inflammasome may be a potential therapeutic strategy in obesity.",
author = "V. Rainone and L. Schneider and I. Saulle and C. Ricci and M. Biasin and Al-Daghri, {N. M.} and E. Giani and Zuccotti, {G. V.} and M. Clerici and D. Trabattoni",
year = "2016",
month = "6",
day = "1",
doi = "10.1038/ijo.2016.26",
language = "English",
volume = "40",
pages = "1026--1033",
journal = "International Journal of Obesity",
issn = "0307-0565",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Upregulation of inflammasome activity and increased gut permeability are associated with obesity in children and adolescents

AU - Rainone, V.

AU - Schneider, L.

AU - Saulle, I.

AU - Ricci, C.

AU - Biasin, M.

AU - Al-Daghri, N. M.

AU - Giani, E.

AU - Zuccotti, G. V.

AU - Clerici, M.

AU - Trabattoni, D.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Background:Immune activation contributes to the persistent state of inflammation associated with metabolic dysfunction in obesity. The specific immune receptors that sense metabolic stress signals and trigger inflammation are nevertheless largely unknown, and little is known on inflammatory and immune gene regulation in obesity.Methods:The study includes a cross-sectional and a longitudinal arm. Forty children and adolescents were enrolled: 22 obese subjects and 18 age-matched normal weight controls. Obese subjects participated in an 18-month therapeutic protocol, based on intensive lifestyle modification (dietary regimen, physical activity and behavioral interventions). Expression of genes involved in the inflammasome pathway, plasma concentration of the inflammasome-associated pro-inflammatory cytokines (interleukin (IL)-1β and IL-18) and indexes of microbial translocation (lipopolysaccharide (LPS), soluble CD14 (sCD14) and intestinal fatty acid-binding protein) were analyzed at baseline in obese subjects compared with controls, and after 18 months in obese subjects.Results:Cross-sectional analyses showed that the LPS-induced expression of genes involved in inflammasome (NLRP3, caspase 5 and NAIP), Nod-like receptors (NLRX1 and NOD1), downstream signaling (P2RX7, RAGE, RIPk2, TIRAP and BIRC2) and effector molecules (IFN-γ, IL-12β, IL-1β, CCL2, CCL5, IL-6 and TNFα) was significantly increased in obese subjects at baseline as compared with normal weight controls. The baseline plasma concentration of inflammasome-related cytokines (IL-1β and IL-18) and of microbial translocation markers (LPS and sCD14) was augmented in obese subjects as compared with controls as well. Longitudinal analyses indicated that intensive lifestyle modification resulted in a normalization of parameters in subjects with a significant reduction of BMI after 18 months.Conclusions:In children and adolescents, obesity is characterized by the activation of the inflammasome and by an alteration of gut permeability. Successful lifestyle modification is effective in reducing inflammation, suggesting that inhibition of the inflammasome may be a potential therapeutic strategy in obesity.

AB - Background:Immune activation contributes to the persistent state of inflammation associated with metabolic dysfunction in obesity. The specific immune receptors that sense metabolic stress signals and trigger inflammation are nevertheless largely unknown, and little is known on inflammatory and immune gene regulation in obesity.Methods:The study includes a cross-sectional and a longitudinal arm. Forty children and adolescents were enrolled: 22 obese subjects and 18 age-matched normal weight controls. Obese subjects participated in an 18-month therapeutic protocol, based on intensive lifestyle modification (dietary regimen, physical activity and behavioral interventions). Expression of genes involved in the inflammasome pathway, plasma concentration of the inflammasome-associated pro-inflammatory cytokines (interleukin (IL)-1β and IL-18) and indexes of microbial translocation (lipopolysaccharide (LPS), soluble CD14 (sCD14) and intestinal fatty acid-binding protein) were analyzed at baseline in obese subjects compared with controls, and after 18 months in obese subjects.Results:Cross-sectional analyses showed that the LPS-induced expression of genes involved in inflammasome (NLRP3, caspase 5 and NAIP), Nod-like receptors (NLRX1 and NOD1), downstream signaling (P2RX7, RAGE, RIPk2, TIRAP and BIRC2) and effector molecules (IFN-γ, IL-12β, IL-1β, CCL2, CCL5, IL-6 and TNFα) was significantly increased in obese subjects at baseline as compared with normal weight controls. The baseline plasma concentration of inflammasome-related cytokines (IL-1β and IL-18) and of microbial translocation markers (LPS and sCD14) was augmented in obese subjects as compared with controls as well. Longitudinal analyses indicated that intensive lifestyle modification resulted in a normalization of parameters in subjects with a significant reduction of BMI after 18 months.Conclusions:In children and adolescents, obesity is characterized by the activation of the inflammasome and by an alteration of gut permeability. Successful lifestyle modification is effective in reducing inflammation, suggesting that inhibition of the inflammasome may be a potential therapeutic strategy in obesity.

UR - http://www.scopus.com/inward/record.url?scp=84961393640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961393640&partnerID=8YFLogxK

U2 - 10.1038/ijo.2016.26

DO - 10.1038/ijo.2016.26

M3 - Article

VL - 40

SP - 1026

EP - 1033

JO - International Journal of Obesity

JF - International Journal of Obesity

SN - 0307-0565

IS - 6

ER -